$
26.760
-0.450(-1.650%)
  • Overview
  • Forecast
  • Valuation
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
27.370
Open
27.080
VWAP
26.99
Vol
37.50K
Mkt Cap
382.65M
Low
26.700
Amount
1.01M
EV/EBITDA(TTM)
85.86
Total Shares
14.26M
EV
387.56M
EV/OCF(TTM)
--
P/S(TTM)
3.18
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
29.68M
-0.8%
-0.040
-0%
31.85M
-4.14%
-0.060
-53.85%
30.30M
-0.12%
-0.077
-71.6%
Estimates Revision
The market is revising Downward the revenue expectations for Surmodics, Inc. (SRDX) for FY2025, with the revenue forecasts being adjusted by -3.28% over the past three months. During the same period, the stock price has changed by -22.70%.
Revenue Estimates for FY2025
Revise Downward
down Image
-3.28%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+45.28%
In Past 3 Month
Stock Price
Go Down
down Image
-22.70%
In Past 3 Month
2 Analyst Rating
up Image
60.69% Upside
Wall Street analysts forecast SRDX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SRDX is 43.00 USD with a low forecast of 43.00 USD and a high forecast of 43.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
up Image
60.69% Upside
Current: 26.760
sliders
Low
43.00
Averages
43.00
High
43.00
Needham
Mike Matson
Hold
Reiterates
n/a
2025-04-30
Reason
Lake Street
Brooks O'Neil
Hold
to
Strong Buy
Upgrades
$43
2025-03-07
Reason
Needham
Mike Matson
Hold
Reiterates
n/a
2025-01-30
Reason
Needham
Mike Matson
Hold
Reiterates
n/a
2024-11-07
Reason
Needham
Mike Matson
Hold
Reiterates
n/a
2024-08-05
Reason
Barrington Research
Michael Petusky
Buy
to
Hold
Downgrades
n/a
2024-05-30
Reason

Valuation Metrics

The current forward P/E ratio for Surmodics Inc (SRDX.O) is -48.01, compared to its 5-year average forward P/E of 664.01. For a more detailed relative valuation and DCF analysis to assess Surmodics Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
664.01
Current PE
-48.01
Overvalued PE
3619.09
Undervalued PE
-2291.07

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
26.68
Current EV/EBITDA
42.31
Overvalued EV/EBITDA
89.06
Undervalued EV/EBITDA
-35.70

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
4.72
Current PS
3.32
Overvalued PS
6.14
Undervalued PS
3.29

Financials

Annual
Quarterly
FY2025Q2
YoY :
-12.12%
28.09M
Total Revenue
FY2025Q2
YoY :
-329.14%
-1.51M
Operating Profit
FY2025Q2
YoY :
-2208.91%
-5.21M
Net Income after Tax
FY2025Q2
YoY :
-1900.00%
-0.36
EPS - Diluted
FY2025Q2
YoY :
-89.75%
630.00K
Free Cash Flow
FY2025Q2
YoY :
-7.94%
69.08
Gross Profit Margin - %
FY2025Q2
YoY :
-138.78%
-6.12
FCF Margin - %
FY2025Q2
YoY :
-2509.09%
-18.55
Net Margin - %
FY2025Q2
N/A
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
276.4K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
466.1K
Volume
3
6-9
Months
0.0
Volume
0
0-12
Months
2.8M
Volume
6
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
2
111.8K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

SRDX News & Events

Events Timeline

2025-04-30 (ET)
2025-04-30
07:37:08
Surmodics sees FY25 EPS (62c)-(42c), consensus (26c)
select
2025-04-30
07:35:01
Surmodics reports Q2 EPS (13c), consensus (11c)
select
2025-04-22 (ET)
2025-04-22
07:31:51
Surmodics publishes TRANSCEND trial data
select
Sign Up For More Events

News

4.0
04-30Benzinga
Needham Reiterates Hold on Surmodicsto Hold
9.5
04-28Yahoo Finance
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
9.0
04-22Newsfilter
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon
Sign Up For More News

FAQ

arrow icon

What is Surmodics Inc (SRDX) stock price today?

The current price of SRDX is 26.76 USD — it has decreased -1.65 % in the last trading day.

arrow icon

What is Surmodics Inc (SRDX)'s business?

arrow icon

What is the price predicton of SRDX Stock?

arrow icon

What is Surmodics Inc (SRDX)'s revenue for the last quarter?

arrow icon

What is Surmodics Inc (SRDX)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Surmodics Inc (SRDX)'s fundamentals?

arrow icon

How many employees does Surmodics Inc (SRDX). have?

arrow icon

What is Surmodics Inc (SRDX) market cap?